Robin Aftuck, CNM
Advanced Practice Midwife · Cuba, NYNPI 1467553347
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $303 and has fallen 63.7% since, to $110 in 2025. Among advanced practice midwife clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$212
- AbbVie$131
- Pfizer$109
- Amgen$109
- Sumitomo Pharma America, Inc.$68
- Organon$64
- plus $282 from 12 others
What the payments were for
- Food & beverage$974100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 12 | $212 |
| AbbVie | 6 | $131 |
| Pfizer | 6 | $109 |
| Amgen | 6 | $109 |
| Sumitomo Pharma America, Inc. | 3 | $68 |
| Organon | 4 | $64 |
| Bayer | 3 | $59 |
| Myriad Women's Health, Inc. | 1 | $45 |
| Merck | 2 | $33 |
| Exeltis, USA Inc. | 2 | $28 |
| Novo Nordisk | 1 | $17 |
| Novartis | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Gilead | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Impel Pharmaceuticals Inc. | 1 | $13 |
| Coopersurgical, Inc. | 1 | $13 |
How this compares
$974 in reported general payments places this provider in the 90th percentile of 364 advanced practice midwife providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Norgestimate-Ethinyl Estradiol | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other advanced practice midwife in Cuba
- Claudia GerstenGlens Falls$21K
- Jessica Lewis-CaporalPoughkeepsie$7K
- Yuliya BoruchNew York$5K
- Lucille MilneWhite Plains$4K
- Cohava Kasaev-ChanimovBronx$3K
- Barla BishopMount Kisco$3K
- Donna GrandHuntington Station$3K
- Dina IsraelovBrooklyn$2K
- Heather FindletarYaphank$2K
- Tamara BurgerJohnson City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.